Technological watch

Total Corbion donates PLA Luminy for the production of 3D printed face shields - Bio-based News -

Total Corbion has donated over a tonne of renewably-sourced PLA Luminy to Ioan Florea, an artist who uses 3D printing technology in creating his art. Florea will use the resin to produce face shields for hospital workers needing protection.

The Luminy PLA plastic pellets were mixed with pigments and processed into filament rolls using multiple extruders. The filament rolls were fed into 12 large scale 3D printers used to print the full frame and closed top face shields, with the entire process taking place in the artist’s studio.

Already, donations have been made to a number of different hospitals, including Mount Sinai Hospital Chicago, Saint Anthony Hospital Chicago/Cook County Chicago, Community Health Chicago, AMITA Health Saint Joseph Hospital Chicago, and NYC Health + Hospitals/Bellevue New York.

Artist Ioan Florea in front of a large 3D printer in his studio; First responders wearing 3D face shields at NYC Health + Hospitals / Bellevue

“Our Special Pathogens group has approved the 3D printed face shields,” said Marcia Peters CQO, Senior Associate Executive Director, Clinical Management.

“On behalf of the leadership and staff at NYC Health + Hospitals/Bellevue, we would like to extend our gratitude for the generous donation of face masks that were made by the artist Ioan Florea. Our goal during the COVID-19 crisis is to prioritize the health and wellness of our essential workforce so that they can continue to provide the best care for our patients.”

“We are energized by the efforts taken by many around the globe to fight the coronavirus,” said François de Bie, Senior Marketing Director at Total Corbion PLA. “With our small donation of Luminy PLA, we are proud to be part of this bigger initiative to help save lives.”

Source: Bioplastics MAGAZINE, 2020-07-23.

Publication date: 11/08/2020

Bio-based News


This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 870292.